Literature DB >> 16000277

Prognostic significance of dipyridamole-induced ST depression in patients with normal 82Rb PET myocardial perfusion imaging.

Benjamin J W Chow1, James W Wong, Keiichiro Yoshinaga, Terrence D Ruddy, Kathryn Williams, Robert A deKemp, Jean DaSilva, Rob S Beanlands.   

Abstract

UNLABELLED: Recent studies have shown that vasodilator-induced ischemic electrocardiographic (ECG) changes have incremental prognostic value over normal SPECT myocardial perfusion imaging (MPI) and identify patients at higher risk for cardiac events. The prognostic value of vasodilator-induced ischemic ECG changes in the setting of normal PET MPI has yet to be determined. We sought to determine the prognostic importance of dipyridamole-induced ischemic ECG changes in patients with normal 82Rb PET myocardial perfusion images.
METHODS: Between 2000 and 2003, 2,029 consecutive patients undergoing dipyridamole stress 82Rb PET at the University of Ottawa Heart Institute were evaluated. Patients with normal PET MPI and interpretable ECGs were enrolled. Electrocardiograms were assessed for ST depression or elevation and patients were categorized into those with and without dipyridamole-induced ischemic ECG changes. Images were graded using the 17-segment model. Follow-up information was obtained by telephone interview, from hospital records, or from treating physicians. All cardiac events (cardiac death, nonfatal myocardial infarction [MI], percutaneous coronary intervention, coronary artery bypass grafting, or angiography) were verified with hospital records.
RESULTS: Of the 629 enrolled patients with normal PET MPI, 72 patients had dipyridamole-induced ischemic ECG changes. There was no significant difference between the 2 groups in the combined endpoint (cardiac death, nonfatal MI, and revascularization) at follow-up (mean +/- SD, 27.1 +/- 13 mo). There were no cardiac deaths in either group. One (1.4%) patient with ischemic ECG changes had a nonfatal MI (0.6% annual event rate). Two (2.8%) patients with ischemic ECG changes required revascularization compared with 11 (2.0%) in the nonischemic ECG group.
CONCLUSION: Normal 82Rb PET confers an excellent prognosis regardless of dipyridamole-induced ST depression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16000277

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  17 in total

1.  ST-segment depression during vasodilator stress is of minor clinical importance in women with normal myocardial perfusion imaging and low or intermediate risk of coronary artery disease.

Authors:  Dimitris J Apostolopoulos; Periklis Davlouros; Sotiria Alexiou; Nikolaos Patsouras; Trifon Spyridonidis; Pavlos J Vassilakos; Dimitrios Alexopoulos
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-12-08       Impact factor: 9.236

2.  Patients with adenosine-induced ST-segment depressions and normal myocardial perfusion imaging: cardiac outcomes at 24 months.

Authors:  Jyoti Sharma; Christine Roncari; Kenneth N Giedd; John T Fox; Yumiko Kanei
Journal:  J Nucl Cardiol       Date:  2010-06-10       Impact factor: 5.952

3.  The vasodilator stress ECG: should depression cause anxiety?

Authors:  Brian G Abbott
Journal:  J Nucl Cardiol       Date:  2012-02       Impact factor: 5.952

Review 4.  Myocardial perfusion scintigraphy: past, present and future.

Authors:  A Notghi; C S Low
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

5.  Diagnosis and prognosis of coronary artery disease: PET is superior to SPECT: Pro.

Authors:  Rob S B Beanlands; George Youssef
Journal:  J Nucl Cardiol       Date:  2010-08       Impact factor: 5.952

6.  CT-based attenuation correction in (82)Rb-myocardial perfusion PET-CT: incidence of misalignment and effect on regional tracer distribution.

Authors:  Riikka Lautamäki; Tracy L Y Brown; Jennifer Merrill; Frank M Bengel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-10-02       Impact factor: 9.236

7.  Relationship between gated myocardial perfusion SPECT findings and hemodynamic, electrocardiographic, and heart rate changes after Dipyridamole infusion.

Authors:  Arash Gholoobi; Narjess Ayati; Alireza Baghyari; Mohsen Mouhebati; Baharak Atar; Vahid Reza Dabbagh Kakhki
Journal:  Int J Cardiovasc Imaging       Date:  2017-02-01       Impact factor: 2.357

8.  Electrocardiographic changes during vasodilator SPECT myocardial perfusion imaging: does it affect diagnosis or prognosis?

Authors:  Talhat Azemi; Mridula Rai; Purvi Parwani; Sarkis Baghdasarian; Fawad Kazi; Alan W Ahlberg; Giselle Cyr; Deborah Katten; David O'Sullivan; Daniel Fram; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2011-09-23       Impact factor: 5.952

9.  Comparison and effectiveness of regadenoson versus dipyridamole on stress electrocardiographic changes during positron emission tomography evaluation of patients with hypertrophic cardiomyopathy.

Authors:  Paco E Bravo; Iraklis Pozios; Aurélio Pinheiro; Jennifer Merrill; Benjamin M W Tsui; Richard L Wahl; Frank M Bengel; M Roselle Abraham; Theodore P Abraham
Journal:  Am J Cardiol       Date:  2012-06-28       Impact factor: 2.778

10.  Determinants of the response of left ventricular ejection fraction to vasodilator stress in electrocardiographically gated (82)rubidium myocardial perfusion PET.

Authors:  Tracy L Y Brown; Jennifer Merrill; Lana Volokh; Frank M Bengel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-10-02       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.